ID   DHPR_HUMAN              Reviewed;         244 AA.
AC   P09417; A8K158; B3KW71; Q53F52; Q9H3M5;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   10-MAY-2017, entry version 193.
DE   RecName: Full=Dihydropteridine reductase;
DE            EC=1.5.1.34;
DE   AltName: Full=HDHPR;
DE   AltName: Full=Quinoid dihydropteridine reductase;
DE   AltName: Full=Short chain dehydrogenase/reductase family 33C member 1;
GN   Name=QDPR; Synonyms=DHPR, SDR33C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-51.
RX   PubMed=3031582; DOI=10.1093/nar/15.5.1921;
RA   Dahl H.-H.M., Hutchison W., McAdam W., Wake S., Morgan F.J.,
RA   Cotton R.G.H.;
RT   "Human dihydropteridine reductase: characterisation of a cDNA clone
RT   and its use in analysis of patients with dihydropteridine reductase
RT   deficiency.";
RL   Nucleic Acids Res. 15:1921-1932(1987).
RN   [2]
RP   SEQUENCE REVISION TO 51.
RA   Dahl H.-H.M.;
RL   Submitted (JUL-1987) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-51.
RX   PubMed=3033643; DOI=10.1073/pnas.84.10.3329;
RA   Lockyer J., Cook R.G., Milstien S., Kaufman S., Woo S.L.C.,
RA   Ledley F.D.;
RT   "Structure and expression of human dihydropteridine reductase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:3329-3333(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-51, AND VARIANTS
RP   HPABH4C ASP-23; CYS-150; TYR-158 AND ILE-THR-GLY-218 INS.
RX   PubMed=9744478;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.3.CO;2-0;
RA   Dianzani I., de Sanctis L., Smooker P.M., Gough T.J., Alliaudi C.,
RA   Brusco A., Spada M., Blau N., Dobos M., Zhang H.-P., Yang N.,
RA   Ponzone A., Armarego W.L.F., Cotton R.G.H.;
RT   "Dihydropteridine reductase deficiency: physical structure of the QDPR
RT   gene, identification of two new mutations and genotype-phenotype
RT   correlations.";
RL   Hum. Mutat. 12:267-273(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hsiao K.-J., Yen P.-F., Lin C.-H., Liu T.-T., Chiang S.-H.,
RA   Chen C.-Y., Tsai S.-F.;
RT   "The complete sequence of human dihydropteridine reductase gene
RT   containing BAC clone 395N09.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-11 AND 128-138, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=8262916;
RA   Su Y., Varughese K.I., Xuong N.H., Bray T.L., Roche D.J.,
RA   Whiteley J.M.;
RT   "The crystallographic structure of a human dihydropteridine reductase
RT   NADH binary complex expressed in Escherichia coli by a cDNA
RT   constructed from its rat homologue.";
RL   J. Biol. Chem. 268:26836-26841(1993).
RN   [18]
RP   REVIEW ON VARIANTS.
RX   PubMed=7627180; DOI=10.1002/humu.1380050402;
RA   Smooker P.M., Cotton R.G.H.;
RT   "Molecular basis of dihydropteridine reductase deficiency.";
RL   Hum. Mutat. 5:279-284(1995).
RN   [19]
RP   VARIANTS HPABH4C ASP-23 AND GLY-108.
RX   PubMed=8326489; DOI=10.1136/jmg.30.6.465;
RA   Dianzani I., Howells D.W., Ponzone A., Saleeba J.A., Smooker P.M.,
RA   Cotton R.G.H.;
RT   "Two new mutations in the dihydropteridine reductase gene in patients
RT   with tetrahydrobiopterin deficiency.";
RL   J. Med. Genet. 30:465-469(1993).
RN   [20]
RP   VARIANT HPABH4C THR-123 INS.
RX   PubMed=2116088;
RA   Howells D.W., Forrest S.M., Dahl H.-H.M., Cotton R.G.H.;
RT   "Insertion of an extra codon for threonine is a cause of
RT   dihydropteridine reductase deficiency.";
RL   Am. J. Hum. Genet. 47:279-285(1990).
RN   [21]
RP   VARIANTS HPABH4C PRO-14 AND VAL-17.
RX   PubMed=10408783;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:6<503::AID-HUMU13>3.0.CO;2-F;
RA   Smooker P.M., Gough T.J., Cotton R.G.H., Alliaudi C., de Sanctis L.,
RA   Dianzani I.;
RT   "A series of mutations in the dihydropteridine reductase gene
RT   resulting in either abnormal RNA splicing or DHPR protein defects.";
RL   Hum. Mutat. 13:503-504(1999).
RN   [22]
RP   VARIANTS HPABH4C ARG-17; ASP-18; ASP-23; ARG-66; ARG-149 AND CYS-150.
RX   PubMed=11153907; DOI=10.1007/s004390000407;
RA   Romstad A., Kalkanoglu H.S., Coskun T., Demirkol M., Tokatli A.,
RA   Dursun A., Baykal T., Oezalp I., Guldberg P., Guettler F.;
RT   "Molecular analysis of 16 Turkish families with DHPR deficiency using
RT   denaturing gradient gel electrophoresis (DGGE).";
RL   Hum. Genet. 107:546-553(2000).
CC   -!- FUNCTION: The product of this enzyme, tetrahydrobiopterin (BH-4),
CC       is an essential cofactor for phenylalanine, tyrosine, and
CC       tryptophan hydroxylases.
CC   -!- CATALYTIC ACTIVITY: A 5,6,7,8-tetrahydropteridine + NAD(P)(+) = a
CC       6,7-dihydropteridine + NAD(P)H.
CC   -!- SUBUNIT: Homodimer.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P09417-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09417-2; Sequence=VSP_054356;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Hyperphenylalaninemia, BH4-deficient, C (HPABH4C)
CC       [MIM:261630]: Rare autosomal recessive disorder characterized by
CC       hyperphenylalaninemia and severe neurologic symptoms (malignant
CC       hyperphenylalaninemia) including axial hypotonia and truncal
CC       hypertonia, abnormal thermogenesis, and microcephaly. These signs
CC       are attributable to depletion of the neurotransmitters dopamine
CC       and serotonin, whose syntheses are controlled by tryptophan and
CC       tyrosine hydroxylases that use BH-4 as cofactor. Patients do not
CC       respond to phenylalanine-restricted diet. HPABH4C is lethal if
CC       untreated. {ECO:0000269|PubMed:10408783,
CC       ECO:0000269|PubMed:11153907, ECO:0000269|PubMed:2116088,
CC       ECO:0000269|PubMed:8326489, ECO:0000269|PubMed:9744478}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04882; CAA28571.1; -; mRNA.
DR   EMBL; M16447; AAA52305.1; -; mRNA.
DR   EMBL; AJ006239; CAA06930.1; -; Genomic_DNA.
DR   EMBL; AJ006240; CAA06930.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006241; CAA06930.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006242; CAA06930.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006243; CAA06930.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006244; CAA06930.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006245; CAA06930.1; JOINED; Genomic_DNA.
DR   EMBL; AB053170; BAB20429.1; -; Genomic_DNA.
DR   EMBL; AK124382; BAG54033.1; -; mRNA.
DR   EMBL; AK289773; BAF82462.1; -; mRNA.
DR   EMBL; AK223437; BAD97157.1; -; mRNA.
DR   EMBL; AC093600; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW92777.1; -; Genomic_DNA.
DR   EMBL; CH471069; EAW92778.1; -; Genomic_DNA.
DR   EMBL; BC000576; AAH00576.1; -; mRNA.
DR   CCDS; CCDS3421.1; -. [P09417-1]
DR   CCDS; CCDS77904.1; -. [P09417-2]
DR   PIR; A93655; RDHUP.
DR   RefSeq; NP_000311.2; NM_000320.2. [P09417-1]
DR   RefSeq; NP_001293069.1; NM_001306140.1. [P09417-2]
DR   UniGene; Hs.75438; -.
DR   PDB; 1HDR; X-ray; 2.50 A; A=1-244.
DR   PDBsum; 1HDR; -.
DR   ProteinModelPortal; P09417; -.
DR   SMR; P09417; -.
DR   BioGrid; 111798; 26.
DR   IntAct; P09417; 4.
DR   MINT; MINT-5002411; -.
DR   STRING; 9606.ENSP00000281243; -.
DR   BindingDB; P09417; -.
DR   ChEMBL; CHEMBL3730; -.
DR   DrugBank; DB03814; 2-(N-Morpholino)-Ethanesulfonic Acid.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P09417; -.
DR   PhosphoSitePlus; P09417; -.
DR   BioMuta; QDPR; -.
DR   DMDM; 118572639; -.
DR   REPRODUCTION-2DPAGE; IPI00014439; -.
DR   UCD-2DPAGE; P09417; -.
DR   EPD; P09417; -.
DR   MaxQB; P09417; -.
DR   PaxDb; P09417; -.
DR   PeptideAtlas; P09417; -.
DR   PRIDE; P09417; -.
DR   DNASU; 5860; -.
DR   Ensembl; ENST00000281243; ENSP00000281243; ENSG00000151552. [P09417-1]
DR   Ensembl; ENST00000428702; ENSP00000390944; ENSG00000151552. [P09417-2]
DR   GeneID; 5860; -.
DR   KEGG; hsa:5860; -.
DR   UCSC; uc003gpd.4; human. [P09417-1]
DR   CTD; 5860; -.
DR   DisGeNET; 5860; -.
DR   GeneCards; QDPR; -.
DR   HGNC; HGNC:9752; QDPR.
DR   HPA; HPA058951; -.
DR   HPA; HPA065649; -.
DR   MalaCards; QDPR; -.
DR   MIM; 261630; phenotype.
DR   MIM; 612676; gene.
DR   neXtProt; NX_P09417; -.
DR   OpenTargets; ENSG00000151552; -.
DR   Orphanet; 226; Dihydropteridine reductase deficiency.
DR   PharmGKB; PA34094; -.
DR   eggNOG; KOG4022; Eukaryota.
DR   eggNOG; ENOG4111D6J; LUCA.
DR   GeneTree; ENSGT00390000000470; -.
DR   HOGENOM; HOG000232194; -.
DR   HOVERGEN; HBG001000; -.
DR   InParanoid; P09417; -.
DR   KO; K00357; -.
DR   OMA; NRKSMPD; -.
DR   OrthoDB; EOG091G0ILG; -.
DR   PhylomeDB; P09417; -.
DR   TreeFam; TF105932; -.
DR   BioCyc; MetaCyc:HS07746-MONOMER; -.
DR   BRENDA; 1.5.1.34; 2681.
DR   Reactome; R-HSA-71182; Phenylalanine and tyrosine catabolism.
DR   SABIO-RK; P09417; -.
DR   ChiTaRS; QDPR; human.
DR   EvolutionaryTrace; P09417; -.
DR   GeneWiki; QDPR; -.
DR   GenomeRNAi; 5860; -.
DR   PRO; PR:P09417; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000151552; -.
DR   CleanEx; HS_QDPR; -.
DR   ExpressionAtlas; P09417; baseline and differential.
DR   Genevisible; P09417; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0004155; F:6,7-dihydropteridine reductase activity; EXP:Reactome.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0070404; F:NADH binding; IEA:Ensembl.
DR   GO; GO:0070402; F:NADPH binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0051066; P:dihydrobiopterin metabolic process; TAS:ProtInc.
DR   GO; GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0010044; P:response to aluminum ion; IEA:Ensembl.
DR   GO; GO:0033762; P:response to glucagon; IEA:Ensembl.
DR   GO; GO:0010288; P:response to lead ion; IEA:Ensembl.
DR   GO; GO:0006729; P:tetrahydrobiopterin biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; NADP; Oxidoreductase;
KW   Phenylketonuria; Polymorphism; Reference proteome;
KW   Tetrahydrobiopterin biosynthesis.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.11}.
FT   CHAIN         2    244       Dihydropteridine reductase.
FT                                /FTId=PRO_0000054636.
FT   NP_BIND      14     38       NADP.
FT   ACT_SITE    150    150       Proton acceptor.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.11}.
FT   MOD_RES      73     73       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BVI4}.
FT   MOD_RES      79     79       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BVI4}.
FT   MOD_RES      96     96       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BVI4}.
FT   MOD_RES     102    102       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BVI4}.
FT   VAR_SEQ      36     66       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054356.
FT   VARIANT      14     14       L -> P (in HPABH4C; severe;
FT                                dbSNP:rs756639609).
FT                                {ECO:0000269|PubMed:10408783}.
FT                                /FTId=VAR_008121.
FT   VARIANT      17     17       G -> R (in HPABH4C; severe;
FT                                dbSNP:rs757483045).
FT                                {ECO:0000269|PubMed:11153907}.
FT                                /FTId=VAR_021767.
FT   VARIANT      17     17       G -> V (in HPABH4C; severe).
FT                                {ECO:0000269|PubMed:10408783}.
FT                                /FTId=VAR_008122.
FT   VARIANT      18     18       G -> D (in HPABH4C; severe).
FT                                {ECO:0000269|PubMed:11153907}.
FT                                /FTId=VAR_021768.
FT   VARIANT      23     23       G -> D (in HPABH4C; severe;
FT                                dbSNP:rs104893863).
FT                                {ECO:0000269|PubMed:11153907,
FT                                ECO:0000269|PubMed:8326489,
FT                                ECO:0000269|PubMed:9744478}.
FT                                /FTId=VAR_006960.
FT   VARIANT      36     36       W -> R (in HPABH4C; dbSNP:rs104893865).
FT                                /FTId=VAR_006961.
FT   VARIANT      51     51       S -> T. {ECO:0000269|PubMed:3031582,
FT                                ECO:0000269|PubMed:3033643,
FT                                ECO:0000269|PubMed:9744478}.
FT                                /FTId=VAR_013027.
FT   VARIANT      66     66       Q -> R (in HPABH4C; severe).
FT                                {ECO:0000269|PubMed:11153907}.
FT                                /FTId=VAR_021769.
FT   VARIANT      74     74       L -> P (in HPABH4C).
FT                                /FTId=VAR_006962.
FT   VARIANT     108    108       W -> G (in HPABH4C; dbSNP:rs104893864).
FT                                {ECO:0000269|PubMed:8326489}.
FT                                /FTId=VAR_006963.
FT   VARIANT     123    123       T -> TT (in HPABH4C).
FT                                {ECO:0000269|PubMed:2116088}.
FT                                /FTId=VAR_006964.
FT   VARIANT     145    145       P -> L (in HPABH4C).
FT                                /FTId=VAR_006965.
FT   VARIANT     149    149       G -> R (in HPABH4C).
FT                                {ECO:0000269|PubMed:11153907}.
FT                                /FTId=VAR_021770.
FT   VARIANT     150    150       Y -> C (in HPABH4C; mild;
FT                                dbSNP:rs104893866).
FT                                {ECO:0000269|PubMed:11153907,
FT                                ECO:0000269|PubMed:9744478}.
FT                                /FTId=VAR_006966.
FT   VARIANT     151    151       G -> S (in HPABH4C; mild).
FT                                /FTId=VAR_006967.
FT   VARIANT     158    158       H -> Y (in HPABH4C; severe;
FT                                dbSNP:rs750201480).
FT                                {ECO:0000269|PubMed:9744478}.
FT                                /FTId=VAR_006968.
FT   VARIANT     170    170       G -> S (in HPABH4C; dbSNP:rs769460415).
FT                                /FTId=VAR_006969.
FT   VARIANT     212    212       F -> C (in HPABH4C; mild).
FT                                /FTId=VAR_006970.
FT   VARIANT     218    218       G -> GITG (in HPABH4C; mild).
FT                                /FTId=VAR_006971.
FT   STRAND       11     16       {ECO:0000244|PDB:1HDR}.
FT   TURN         17     19       {ECO:0000244|PDB:1HDR}.
FT   HELIX        21     32       {ECO:0000244|PDB:1HDR}.
FT   STRAND       36     43       {ECO:0000244|PDB:1HDR}.
FT   STRAND       48     53       {ECO:0000244|PDB:1HDR}.
FT   HELIX        60     75       {ECO:0000244|PDB:1HDR}.
FT   STRAND       80     85       {ECO:0000244|PDB:1HDR}.
FT   HELIX       100    110       {ECO:0000244|PDB:1HDR}.
FT   HELIX       112    125       {ECO:0000244|PDB:1HDR}.
FT   STRAND      126    135       {ECO:0000244|PDB:1HDR}.
FT   HELIX       138    141       {ECO:0000244|PDB:1HDR}.
FT   HELIX       148    165       {ECO:0000244|PDB:1HDR}.
FT   STRAND      176    181       {ECO:0000244|PDB:1HDR}.
FT   HELIX       188    191       {ECO:0000244|PDB:1HDR}.
FT   HELIX       199    201       {ECO:0000244|PDB:1HDR}.
FT   HELIX       205    216       {ECO:0000244|PDB:1HDR}.
FT   TURN        217    220       {ECO:0000244|PDB:1HDR}.
FT   STRAND      227    233       {ECO:0000244|PDB:1HDR}.
FT   STRAND      236    242       {ECO:0000244|PDB:1HDR}.
SQ   SEQUENCE   244 AA;  25790 MW;  0852F9F0CA38AB1C CRC64;
     MAAAAAAGEA RRVLVYGGRG ALGSRCVQAF RARNWWVASV DVVENEEASA SIIVKMTDSF
     TEQADQVTAE VGKLLGEEKV DAILCVAGGW AGGNAKSKSL FKNCDLMWKQ SIWTSTISSH
     LATKHLKEGG LLTLAGAKAA LDGTPGMIGY GMAKGAVHQL CQSLAGKNSG MPPGAAAIAV
     LPVTLDTPMN RKSMPEADFS SWTPLEFLVE TFHDWITGKN RPSSGSLIQV VTTEGRTELT
     PAYF
//
